| dbo:abstract
|
- ريتشارد سايكس (بالإنجليزية: Richard Sykes) هو كيميائي وعالم كيمياء حيوية وشخصية أعمال بريطاني، ولد في 7 أغسطس 1942 في يوركشاير في المملكة المتحدة. (ar)
- Sir Richard Sykes (* 1942 in Yorkshire, England) ist ein britischer Biochemiker und Mikrobiologe. (de)
- Richard Brook Sykes, DSc, FRS, FMedSci, HonFREng (7 de agosto de 1942) es presidente de la Royal Institution, Imperial Universitario Healthcare y canciller de Brunel University London. Sykes también preside la Fundación de Médula ósea de Reino Unido y es director no ejecutivo de Lonza AG. (es)
- Sir Richard Brook Sykes, FRS FMedSci HonFREng (born 7 August 1942) is a British microbiologist, the chair of the Royal Institution, the UK Stem Cell Foundation, and the trustees at King Edward VII's Hospital, and chancellor of Brunel University. As of June 2021, he is chair of the UK's Vaccine Taskforce, where he is responsible for overseeing the delivery of the COVID-19 vaccination programme, including preparations for booster programmes and encouraging vaccine innovation in the UK. In 1972, after gaining a first class bachelor's degree and a doctorate, both in microbiology, Sykes was appointed head of the Antibiotic Resistance Unit at Glaxo, where he helped develop the antibiotic ceftazidime. Subsequently, he was recruited by the Squibb Institute, in the United States, where he then developed aztreonam, the first clinically effective monobactam, a term he coined in 1981 to describe a new group of monocyclic β-lactams produced by bacteria. He oversaw the merger of Glaxo with Wellcome, to form Glaxo-Wellcome in 1995 and became its chair two years later. He then oversaw the Glaxo Wellcome and SmithKline Beecham merger and held its chair until 2001. His other appointments have included being rector of Imperial College from 2001 to 2008, chairman of NHS London from December 2008 to July 2010, vice-chairman of Lonza Group until 2013, and chairman of Imperial College Healthcare from 2012 to 2018. (en)
- Сэр Ричард Сайкс (англ. Sir Richard Sykes; род. 7 августа 1942 года) — старший независимый директор и неисполнительный заместитель Председателя ENRC, а также Председатель Комитета по вознаграждениям ENRC. Сэр Ричард в настоящее время занимает должность Председателя фонда The UK Stem Cell и Неисполнительного директора Lonza AG. Также Сэр Ричард являлся членом совета Королевского Общества и опекуном Музея Естественной Истории (в Лондоне) и Королевских Ботанических Садов ('Кю Гарденс', на западе Лондона). Он был руководителем корпорации GlaxoSmithKline и Президентом ассоциации развития науки Великобритании. Наиболее широко известен внедрением лекарственного препарата Ранитидин (Zantac) во время своего пребывания на посту руководителя GlaxoSmithKline. (ru)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthName
| |
| dbo:birthPlace
| |
| dbo:institution
| |
| dbo:knownFor
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 35675 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:after
| |
| dbp:almaMater
|
- Queen Elizabeth College (en)
- University of Bristol (en)
- (en)
- Brunel University (en)
|
| dbp:awards
| |
| dbp:before
| |
| dbp:birthDate
| |
| dbp:birthName
| |
| dbp:birthPlace
|
- Huddersfield, West Yorkshire, England (en)
|
| dbp:education
|
- *Royds Hall Grammar school
*Paddington Technical College
*Chelsea College
*Queen Elizabeth College
*University of Bristol (en)
|
| dbp:fields
|
- * Microbiology
* Antibiotics (en)
|
| dbp:honorificPrefix
| |
| dbp:knownFor
|
- * Monobactam
*Formation of Glaxo-Wellcome
*Formation of GlaxoSmithKline
*Rector of Imperial College
*Chair of Royal Institution (en)
|
| dbp:name
| |
| dbp:nationality
| |
| dbp:title
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
|
- Eurasian Natural Resources Corporation (en)
- Imperial College Healthcare (en)
- Imperial College London (en)
- Natural History Museum, London (en)
- Royal Botanic Gardens, Kew (en)
- (en)
- Brunel University (en)
- GlaxoSmithKline (en)
- NHS London (en)
- Squibb Institute for Medical Research (en)
- Reform think tank (en)
|
| dbp:years
|
- 2000 (xsd:integer)
- 2013 (xsd:integer)
|
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- ريتشارد سايكس (بالإنجليزية: Richard Sykes) هو كيميائي وعالم كيمياء حيوية وشخصية أعمال بريطاني، ولد في 7 أغسطس 1942 في يوركشاير في المملكة المتحدة. (ar)
- Sir Richard Sykes (* 1942 in Yorkshire, England) ist ein britischer Biochemiker und Mikrobiologe. (de)
- Richard Brook Sykes, DSc, FRS, FMedSci, HonFREng (7 de agosto de 1942) es presidente de la Royal Institution, Imperial Universitario Healthcare y canciller de Brunel University London. Sykes también preside la Fundación de Médula ósea de Reino Unido y es director no ejecutivo de Lonza AG. (es)
- Sir Richard Brook Sykes, FRS FMedSci HonFREng (born 7 August 1942) is a British microbiologist, the chair of the Royal Institution, the UK Stem Cell Foundation, and the trustees at King Edward VII's Hospital, and chancellor of Brunel University. As of June 2021, he is chair of the UK's Vaccine Taskforce, where he is responsible for overseeing the delivery of the COVID-19 vaccination programme, including preparations for booster programmes and encouraging vaccine innovation in the UK. (en)
- Сэр Ричард Сайкс (англ. Sir Richard Sykes; род. 7 августа 1942 года) — старший независимый директор и неисполнительный заместитель Председателя ENRC, а также Председатель Комитета по вознаграждениям ENRC. Сэр Ричард в настоящее время занимает должность Председателя фонда The UK Stem Cell и Неисполнительного директора Lonza AG. (ru)
|
| rdfs:label
|
- ريتشارد سايكس (ar)
- Richard Sykes (Biochemiker) (de)
- Richard Sykes (bioquímico) (es)
- Richard Sykes (microbiologist) (en)
- Сайкс, Ричард (ru)
- 理查德·布鲁克·赛克斯 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
